Mouse vWF(Von Willebrand Factor) ELISA Kit
Human Von Willebrand Factor (vWF) ELISA Kit |
|||
DLR-vWF-Hu-48T | DL Develop | 48T | 574.8 EUR |
Description: A sandwich quantitative ELISA assay kit for detection of Human Von Willebrand Factor (vWF) in samples from plasma or other biological fluids. |
|||
Human Von Willebrand Factor (vWF) ELISA Kit |
|||
DLR-vWF-Hu-96T | DL Develop | 96T | 745.2 EUR |
Description: A sandwich quantitative ELISA assay kit for detection of Human Von Willebrand Factor (vWF) in samples from plasma or other biological fluids. |
|||
Porcine Von Willebrand Factor (vWF) ELISA Kit |
|||
DLR-vWF-p-48T | DL Develop | 48T | 656.4 EUR |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Porcine Von Willebrand Factor (vWF) in samples from plasma or other biological fluids. |
|||
Porcine Von Willebrand Factor (vWF) ELISA Kit |
|||
DLR-vWF-p-96T | DL Develop | 96T | 858 EUR |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Porcine Von Willebrand Factor (vWF) in samples from plasma or other biological fluids. |
|||
Rat Von Willebrand Factor (vWF) ELISA Kit |
|||
DLR-vWF-Ra-48T | DL Develop | 48T | 609.6 EUR |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat Von Willebrand Factor (vWF) in samples from plasma. |
|||
Rat Von Willebrand Factor (vWF) ELISA Kit |
|||
DLR-vWF-Ra-96T | DL Develop | 96T | 793.2 EUR |
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rat Von Willebrand Factor (vWF) in samples from plasma. |
|||
Canine Von Willebrand Factor (vWF) ELISA Kit |
|||
RD-vWF-c-48Tests | Reddot Biotech | 48 Tests | 639.6 EUR |
Canine Von Willebrand Factor (vWF) ELISA Kit |
|||
RD-vWF-c-96Tests | Reddot Biotech | 96 Tests | 888 EUR |
Human Von Willebrand Factor (vWF) ELISA Kit |
|||
RD-vWF-Hu-48Tests | Reddot Biotech | 48 Tests | 573.6 EUR |
Human Von Willebrand Factor (vWF) ELISA Kit |
|||
RD-vWF-Hu-96Tests | Reddot Biotech | 96 Tests | 794.4 EUR |
Porcine Von Willebrand Factor (vWF) ELISA Kit |
|||
RD-vWF-p-48Tests | Reddot Biotech | 48 Tests | 666 EUR |
Porcine Von Willebrand Factor (vWF) ELISA Kit |
|||
RD-vWF-p-96Tests | Reddot Biotech | 96 Tests | 925.2 EUR |
Rat Von Willebrand Factor (vWF) ELISA Kit |
|||
RD-vWF-Ra-48Tests | Reddot Biotech | 48 Tests | 613.2 EUR |
Rat Von Willebrand Factor (vWF) ELISA Kit |
|||
RD-vWF-Ra-96Tests | Reddot Biotech | 96 Tests | 850.8 EUR |
Canine Von Willebrand Factor (vWF) ELISA Kit |
|||
RDR-vWF-c-48Tests | Reddot Biotech | 48 Tests | 668.4 EUR |
Canine Von Willebrand Factor (vWF) ELISA Kit |
|||
RDR-vWF-c-96Tests | Reddot Biotech | 96 Tests | 928.8 EUR |
Human Von Willebrand Factor (vWF) ELISA Kit |
|||
RDR-vWF-Hu-48Tests | Reddot Biotech | 48 Tests | 600 EUR |
Human Von Willebrand Factor (vWF) ELISA Kit |
|||
RDR-vWF-Hu-96Tests | Reddot Biotech | 96 Tests | 830.4 EUR |
Porcine Von Willebrand Factor (vWF) ELISA Kit |
|||
RDR-vWF-p-48Tests | Reddot Biotech | 48 Tests | 696 EUR |
Porcine Von Willebrand Factor (vWF) ELISA Kit |
|||
RDR-vWF-p-96Tests | Reddot Biotech | 96 Tests | 968.4 EUR |
Rat Von Willebrand Factor (vWF) ELISA Kit |
|||
RDR-vWF-Ra-48Tests | Reddot Biotech | 48 Tests | 640.8 EUR |
Rat Von Willebrand Factor (vWF) ELISA Kit |
|||
RDR-vWF-Ra-96Tests | Reddot Biotech | 96 Tests | 890.4 EUR |
Von Willebrand Factor (VWF) |
|||
RA25102 | Neuromics | 0.1 ml | 757.2 EUR |
Mouse von Willebrand factor (Vwf) |
|||
1-CSB-EP025960MO | Cusabio |
|
|
Description: Recombinant Mouse von Willebrand factor(Vwf),partial expressed in E.coli |
|||
Mouse von Willebrand factor (Vwf) |
|||
1-CSB-YP025960MO | Cusabio |
|
|
Description: Recombinant Mouse von Willebrand factor(Vwf),partial expressed in Yeast |
|||
Mouse von Willebrand Factor (vWF) ELISA Kit |
|||
20-abx156713 | Abbexa |
|
|
Mouse von Willebrand Factor (vWF) ELISA Kit |
|||
20-abx053088 | Abbexa |
|
|
Mouse von Willebrand Factor (vWF) ELISA Kit |
|||
abx254817-96tests | Abbexa | 96 tests | 848.4 EUR |
Mouse von Willebrand Factor (vWF) ELISA Kit |
|||
abx571958-96tests | Abbexa | 96 tests | 848.4 EUR |
Mouse von Willebrand Factor, vWF ELISA Kit |
|||
CSB-E08439m-24T | Cusabio | 1 plate of 24 wells | 198 EUR |
Description: Quantitativesandwich ELISA kit for measuring Mouse von Willebrand Factor, vWF in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Mouse von Willebrand Factor, vWF ELISA Kit |
|||
1-CSB-E08439m | Cusabio |
|
|
Description: Quantitativesandwich ELISA kit for measuring Mouse von Willebrand Factor, vWF in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Mouse von Willebrand Factor,vWF ELISA Kit |
|||
CN-02705M1 | ChemNorm | 96T | 591.6 EUR |
Mouse von Willebrand Factor,vWF ELISA Kit |
|||
CN-02705M2 | ChemNorm | 48T | 410.4 EUR |
Mouse Von Willebrand Factor (vWF) ELISA Kit |
|||
CEA833Mu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 5269.39 EUR |
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Mouse Von Willebrand Factor (vWF) in plasma. |
|||
Mouse Von Willebrand Factor (vWF) ELISA Kit |
|||
CEA833Mu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 539.12 EUR |
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Mouse Von Willebrand Factor (vWF) in plasma. |
|||
Mouse Von Willebrand Factor (vWF) ELISA Kit |
|||
CEA833Mu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 718.75 EUR |
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Mouse Von Willebrand Factor (vWF) in plasma. |
|||
Mouse Von Willebrand Factor (vWF) ELISA Kit |
|||
CEA833Mu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 2874.38 EUR |
Description: This is Competitive Enzyme-linked immunosorbent assay for detection of Mouse Von Willebrand Factor (vWF) in plasma. |
|||
Mouse Von Willebrand Factor (vWF) ELISA Kit |
|||
4-CEA833Mu | Cloud-Clone |
|
|
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Mouse Von Willebrand Factor (vWF) in samples from plasma with no significant corss-reactivity with analogues from other species. |
|||
Mouse Vwf(von Willebrand factor) ELISA Kit |
|||
EM0464 | FN Test | 96T | 628.92 EUR |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 0.75 ng/ml |
|||
Mouse Vwf/ von Willebrand factor ELISA Kit |
|||
E1583Mo | Sunlong | 1 Kit | 685.2 EUR |
Mouse von Willebrand Factor(vWF)ELISA Kit |
|||
GA-E0286MS-48T | GenAsia Biotech | 48T | 403.2 EUR |
Mouse von Willebrand Factor(vWF)ELISA Kit |
|||
GA-E0286MS-96T | GenAsia Biotech | 96T | 640.8 EUR |
Mouse von Willebrand factor, Vwf ELISA KIT |
|||
ELI-02815m | Lifescience Market | 96 Tests | 1038 EUR |
Mouse von Willebrand Factor(vWF)ELISA Kit |
|||
QY-E21616 | Qayee Biotechnology | 96T | 495.6 EUR |
Mouse Von Willebrand Factor ELISA Kit (vWF) |
|||
RK03287 | Abclonal | 96 Tests | 625.2 EUR |
Mouse von Willebrand Factor,vWF ELISA Kit |
|||
YLA0184MO-48T | Shanghai YL Biotech | 48T | 465 EUR |
Mouse von Willebrand Factor,vWF ELISA Kit |
|||
YLA0184MO-96T | Shanghai YL Biotech | 96T | 600 EUR |
Mouse Von Willebrand Factor (vWF) Protein |
|||
20-abx069688 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx102078 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx102079 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx102080 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx102081 | Abbexa |
|
|
von Willebrand Factor (vWF) Antibody |
|||
20-abx102082 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx102083 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx104899 | Abbexa |
|
|
von Willebrand Factor (vWF) Antibody |
|||
abx038143-100ug | Abbexa | 100 ug | 469.2 EUR |
von Willebrand Factor (vWF) Antibody |
|||
20-abx001191 | Abbexa |
|
|
von Willebrand Factor (vWF) Antibody |
|||
20-abx110351 | Abbexa |
|
|
von Willebrand Factor (vWF) Antibody |
|||
20-abx116635 | Abbexa |
|
|
von Willebrand Factor (vWF) Antibody |
|||
abx036599-100ug | Abbexa | 100 ug | 469.2 EUR |
von Willebrand Factor (vWF) Antibody |
|||
abx037367-100ug | Abbexa | 100 ug | 469.2 EUR |
Von Willebrand Factor (VWF) Antibody |
|||
20-abx210323 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx178898 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx178899 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx178900 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx178901 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx178903 | Abbexa |
|
|
Von Willebrand Factor (VWF) Antibody |
|||
20-abx210608 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx175114 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx175115 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx175116 | Abbexa |
|
|
Von Willebrand Factor (vWF) Antibody |
|||
20-abx175117 | Abbexa |
|
|
Recombinant Von Willebrand Factor (vWF) |
|||
4-RPA833Ca01 | Cloud-Clone |
|
|
Description: Recombinant Dog Von Willebrand Factor expressed in: E.coli |
|||
Recombinant Von Willebrand Factor (vWF) |
|||
4-RPA833Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human Von Willebrand Factor expressed in: E.coli |
|||
Recombinant Von Willebrand Factor (vWF) |
|||
4-RPA833Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse Von Willebrand Factor expressed in: E.coli |
|||
Recombinant Von Willebrand Factor (vWF) |
|||
4-RPA833Po01 | Cloud-Clone |
|
|
Description: Recombinant Pig Von Willebrand Factor expressed in: E.coli |
|||
Recombinant Von Willebrand Factor (vWF) |
|||
4-RPA833Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat Von Willebrand Factor expressed in: E.coli |
|||
Recombinant Von Willebrand Factor (vWF) |
|||
4-RPA833Ra02 | Cloud-Clone |
|
|
Description: Recombinant Rat Von Willebrand Factor expressed in: E.coli |
|||
von Willebrand Factor Antibody / vWF |
|||
RQ5050 | NSJ Bioreagents | 100ul | 419 EUR |
von Willebrand Factor Antibody (vWF) |
|||
F52535-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
von Willebrand Factor Antibody / vWF |
|||
V8164-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V8164-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V8164SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V8165-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V8165-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: Von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V8165SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: Von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V8821-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi s sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V8821-20UG | NSJ Bioreagents | 20ug | 219 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi s sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V8821SAF-100UG | NSJ Bioreagents | 100ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi s sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V9099-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V9099-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V9099SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V2929-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V2929-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V2929SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3233-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3233-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3233SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3417-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3417-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3417SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3418-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3418-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3418SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3491-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3491-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3491IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3491SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3686-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3686-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3686IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V3686SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi's sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V7082-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a glycoprotein produced by bone marrow cells and endothelial cells lining the inside surface of blood vessels. Its primary function is platelet adhesion, binding to Factor VIII, collagen and platelets, to coagulate blood at the site of wounding. The enzyme VWFCP, or vWF-cleaving protease, facilitates clotting by cutting the protein into subunits, increasing its binding capacity. Deficiency or dysfunction of the protein increases the tendency of wounds to bleed, or to bleed more. �Over 300 gene mutations have been identified and classified into three types. �Type 1 von Willebrand Factor disease is characterized by reduced amounts in the bloodstream, Type 2 by reduced binding ability and Type 3 by a nonfunctional protein. |
|||
von Willebrand Factor Antibody / vWF |
|||
V7082-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: von Willebrand Factor (vWF) is a glycoprotein produced by bone marrow cells and endothelial cells lining the inside surface of blood vessels. Its primary function is platelet adhesion, binding to Factor VIII, collagen and platelets, to coagulate blood at the site of wounding. The enzyme VWFCP, or vWF-cleaving protease, facilitates clotting by cutting the protein into subunits, increasing its binding capacity. Deficiency or dysfunction of the protein increases the tendency of wounds to bleed, or to bleed more. �Over 300 gene mutations have been identified and classified into three types. �Type 1 von Willebrand Factor disease is characterized by reduced amounts in the bloodstream, Type 2 by reduced binding ability and Type 3 by a nonfunctional protein. |
|||
von Willebrand Factor Antibody / vWF |
|||
V7082SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a glycoprotein produced by bone marrow cells and endothelial cells lining the inside surface of blood vessels. Its primary function is platelet adhesion, binding to Factor VIII, collagen and platelets, to coagulate blood at the site of wounding. The enzyme VWFCP, or vWF-cleaving protease, facilitates clotting by cutting the protein into subunits, increasing its binding capacity. Deficiency or dysfunction of the protein increases the tendency of wounds to bleed, or to bleed more. �Over 300 gene mutations have been identified and classified into three types. �Type 1 von Willebrand Factor disease is characterized by reduced amounts in the bloodstream, Type 2 by reduced binding ability and Type 3 by a nonfunctional protein. |
|||
von Willebrand Factor Antibody / vWF |
|||
V2298-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This vWF antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi�s sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V2298-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: von Willebrand Factor is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This vWF antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi�s sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V2298SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor is a multimeric glycoprotein that is found in endothelial cells, plasma and platelets. It acts as a carrier protein for Factor VIII and promotes platelet adhesion and aggregation. vWF undergoes a variety of posttranslational modifications that influence the affinity and availability for Factor VIII, including cleavage of the propeptide and formation of N-terminal disulfide bonds. This vWF antibody helps to establish the endothelial nature of some lesions of disputed histogenesis, e.g. Kaposi�s sarcoma and cardiac myxoma. It is widely used for differentiating vascular lesions from those of other tissue differentiation within a panel of other vascular markers although not all tumors of endothelial differentiation contain this antigen. |
|||
von Willebrand Factor Antibody / vWF |
|||
V2299-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a glycoprotein produced by bone marrow cells and endothelial cells lining the inside surface of blood vessels. Its primary function is platelet adhesion, binding to Factor VIII, collagen and platelets, to coagulate blood at the site of wounding. The enzyme VWFCP, or vWF-cleaving protease, facilitates clotting by cutting the protein into subunits, increasing its binding capacity. Deficiency or dysfunction of the protein increases the tendency of wounds to bleed, or to bleed more. Over 300 gene mutations have been identified and classified into three types. Type 1 von Willebrand Factor disease is characterized by reduced amounts in the bloodstream, Type 2 by reduced binding ability and Type 3 by a nonfunctional protein. |
|||
von Willebrand Factor Antibody / vWF |
|||
V2299-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: von Willebrand Factor (vWF) is a glycoprotein produced by bone marrow cells and endothelial cells lining the inside surface of blood vessels. Its primary function is platelet adhesion, binding to Factor VIII, collagen and platelets, to coagulate blood at the site of wounding. The enzyme VWFCP, or vWF-cleaving protease, facilitates clotting by cutting the protein into subunits, increasing its binding capacity. Deficiency or dysfunction of the protein increases the tendency of wounds to bleed, or to bleed more. Over 300 gene mutations have been identified and classified into three types. Type 1 von Willebrand Factor disease is characterized by reduced amounts in the bloodstream, Type 2 by reduced binding ability and Type 3 by a nonfunctional protein. |
|||
von Willebrand Factor Antibody / vWF |
|||
V2299SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: von Willebrand Factor (vWF) is a glycoprotein produced by bone marrow cells and endothelial cells lining the inside surface of blood vessels. Its primary function is platelet adhesion, binding to Factor VIII, collagen and platelets, to coagulate blood at the site of wounding. The enzyme VWFCP, or vWF-cleaving protease, facilitates clotting by cutting the protein into subunits, increasing its binding capacity. Deficiency or dysfunction of the protein increases the tendency of wounds to bleed, or to bleed more. Over 300 gene mutations have been identified and classified into three types. Type 1 von Willebrand Factor disease is characterized by reduced amounts in the bloodstream, Type 2 by reduced binding ability and Type 3 by a nonfunctional protein. |
|||
Mouse von Willebrand Factor (vWF) CLIA Kit |
|||
abx195597-96tests | Abbexa | 96 tests | 990 EUR |
Mouse von Willebrand Factor (vWF) CLIA Kit |
|||
20-abx490265 | Abbexa |
|
|
ELISA kit for Mouse vWF (Von Willebrand Factor) |
|||
ELK5211 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
Description: A competitive Inhibition ELISA kit for detection of Von Willebrand Factor from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
ELISA kit for Mouse vWF (von Willebrand Factor) |
|||
E-EL-M1247 | Elabscience Biotech | 1 plate of 96 wells | 640.8 EUR |
Description: A sandwich ELISA kit for quantitative measurement of Mouse vWF (von Willebrand Factor) in samples from Serum, Plasma, Cell supernatant |
|||
Pig von Willebrand Factor (vWF) ELISA Kit |
|||
20-abx155026 | Abbexa |
|
|
Rabbit von Willebrand Factor (vWF) ELISA Kit |
|||
20-abx155124 | Abbexa |
|
|
Rat von Willebrand Factor (vWF) ELISA Kit |
|||
20-abx156233 | Abbexa |
|
|
Human von Willebrand Factor (vWF) ELISA Kit |
|||
20-abx153489 | Abbexa |
|
|
Pig von Willebrand Factor (vWF) ELISA Kit |
|||
abx255580-96tests | Abbexa | 96 tests | 943.2 EUR |
Human von Willebrand Factor (vWF) ELISA Kit |
|||
abx250306-96tests | Abbexa | 96 tests | 904.8 EUR |
Human Von Willebrand Factor (vWF) ELISA Kit |
|||
20-abx585037 | Abbexa |
|
|
Chicken von Willebrand Factor (vWF) ELISA Kit |
|||
abx356395-96tests | Abbexa | 96 tests | 990 EUR |
Cow von Willebrand Factor (vWF) ELISA Kit |
|||
abx514137-96tests | Abbexa | 96 tests | 1093.2 EUR |
Human von Willebrand Factor (vWF) ELISA Kit |
|||
abx570086-96tests | Abbexa | 96 tests | 904.8 EUR |
Dog von Willebrand Factor (vWF) ELISA Kit |
|||
abx573728-96tests | Abbexa | 96 tests | 1093.2 EUR |
Mouse vWF(Von Willebrand Factor) ELISA Kit